Apr. 14 at 3:32 AM
$TVTX this reminds me of
$QURE on Sept 24th, 2025. They voluntarily halted the stock in order to have an emergency press release and conference call to announce stellar results from their phase I/II trial in Huntington's disease.
After the morning conference call, and right before the market opened, they unhalted it and the share price went from
$13.66 before the halt to
$39.36 at the open. Then it kept going up to
$59 two days later and on it's way to
$70 after a couple of weeks. The only reason it crashed is because Marty Makary went on CNBC and said that they were not going to approve a gene therapy for Huntingtons that drills into peoples skulls. They completely singled out
$QURE.
Fortunately, thats not the situation with
$TVTX because this is actual FDA approval in a lucrative indication, not just good trial results.
Also note,
$QURE had about the same short float % during that run up as
$TRTX currently has. We could see a similar couple weeks once this halt is removed.
